Octagon Capital Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$5.13M Sell
2022
Q4
$11.7M Hold
2022
Q3
$10.3M Buy